Editorial policy

Scope of the journal

Eurosurveillance aims to be the authoritative and representative public health voice of the communicable disease community in Europe and beyond. Our main focus is on Europe, and authors from other parts of the world are encouraged to submit articles, provided that they add value to a European audience. 

Our main objectives are to:

  • provide facts and guidance for health professionals and decision-makers to facilitate the implementation of effective prevention and control measures;
  • support the preparedness and response to health threats in Europe through the rapid dissemination of high-quality authoritative scientific information on relevant outbreaks or emergency situations;
  • provide a European-specific platform for health professionals to share scientific findings in infectious disease epidemiology, prevention and control;
  • disseminate surveillance data on communicable diseases and publish analyses and interpretations of these data;
  • offer, where possible, assistance to authors from all European Union countries in improving the impact and quality of national information on communicable diseases.

All Eurosurveillance content is open access, free of charge for both readers and authors. All articles are indexed by PubMed/MEDLINE, PubMed Central (PMC), Scopus, EMBASE, EBSCO and Science Central databases and undergo a rigorous peer review by independent reviewers to guarantee unbiased selection based on scientific quality.

The Eurosurveillance way 

We are a small enthusiastic editorial team and enjoy personalised contact with our authors. We provide a high level of editorial support and see it as a service to our readers and authors to ensure that each published article is as correct and readable as possible within the constraints of time and resources. After acceptance, during the editing process we work extensively to finalise the manuscript in close collaboration with the authors. 

Details of our evaluation and peer review process are described in our For authors pages 

Target readership 

Eurosurveillance is primarily aimed at all those concerned with communicable disease epidemiology, prevention and control in Europe and beyond. In addition to public health professionals and decision-makers at all levels, medical practitioners, microbiologists, veterinarians and scientists in the field of communicable diseases and members of the relevant health organisations, the journal may also be of interest to professionals from other related fields such as pharmacists, behavioural scientists, anthropologists and scientific journalists. 

Topics and contents 

We publish preliminary outbreak reports and alerts in the form of rapid communications, as well as in-depth analyses of outbreaks and epidemiological disease patterns based on surveillance data and scientific studies. We also cover practices, policies and guidance regarding communicable disease prevention and control, major developments in the field of diagnostics, immunisation, drug resistance and therapy, and summaries of reports from national institutions/organisations. Letters to the editor provide a platform for scientific debate on articles published recently in Eurosurveillance

Our website also offers news on current public health developments and announcements of other topics of interests. 

Most articles in Eurosurveillance concern infectious disease events and trends in Europe, but we also report events from other parts of the world, particularly regarding emerging communicable diseases or developments of importance to Europe. In specific circumstances, Eurosurveillance may cover other potential threats to the health of European citizens. 

More information on the article categories and formats can be found in the For authors section.


Eurosurveillance is published in English. In the Archives, some full articles and abstracts published before 2008 are also available in French, Spanish, Italian or Portuguese. 

Depositing sequence data

Prior to submission of regular articles, nucleic acid sequence data found and presented in the studies reported should have been deposited in sustainable, public, and open access, databases. The deposited sequences should not only include assemblies, but also the raw sequence data. For next generation sequencing, it is important that the FASTQ files are deposited. In regular manuscripts submitted to Eurosurveillance, authors should refer to the location of the sequences/sequence data in the appropriate database of their choice. If this is in the form of accession numbers, these should be available in regular manuscripts upon submission to Eurosurveillance.

For rapid communications, nucleotide acid and protein sequence data should be deposited, as for regular articles. If the accession numbers of the sequences are not yet available upon submission of the rapid communication to Eurosurveillance, proof of submission to an appropriate sequence database is required.

Databases that are suitable for depositing sequence data include, but are not limited to: the European Nucleotide Archive (ENA), GenBank, DNA DataBank of Japan (DDBJ), Global Initiative on Sharing All Influenza Data (GISAID) and Measles Nucleotide Surveillance (MeaNS) databases for nucleotide sequences. Protein sequences can, for example, be deposited to UniProt.

Ethical issues

The ECDC grants editorial freedom to the editorial team of Eurosurveillance.

Eurosurveillance follows guidelines on editorial independence produced by the World Association of Medical Editors (see Relationship between Editors and Owners) and the Code of Conduct produced by the Committee on Publication Ethics. 

Since January 2010, Eurosurveillance has been accredited by the Health on the Net (HON) Foundation as adhering to the HON code of conduct (HONcode). HON is a non-governmental, non-profit organisation with the purpose of supporting users to identify sound, reliable and trustworthy health information on the Internet. 

Eurosurveillance follows the International Committee of Medical Journal Editors (ICMJE) Uniform Requirements for Manuscripts Submitted to Biomedical Journals. 

Data protection

The personal information collected by Eurosurveillance will be processed in line with Regulation (EC) No 45/2001 of the European Parliament and of the Council of 18 December 2000 on the protection of individuals with regard to the processing of personal data by the Community institutions and bodies and on the free movement of such data. 

Pursuant to art. 11 of the Regulation, the following information is given to the data subjects: the data controller is Editor in chief of Eurosurveillance ([email protected]). 

Purpose of the processing is to distribute the journal to interested receivers and where appropriate to communicate important information directly related to Eurosurveillance.  Data is stored in cloud services hosted with Amazon Web Services managed by the company Ingenta. The servers are located in the European Union. 

To register to the Eurosurveillance website, family name, first name, country and email address are mandatory. Once registered, data subjects are able to set up alerts to receive the weekly Eurosurveillance table of contents, and further customised alerts according to their preferences. Through the website, data subjects can exercise their right to access and rectify their personal data, including to unsubscribe. To erase the data, data subjects shall make formal request to the data controller. 

Data will be stored until the data subject requests the erasure, or as long as Amazon Web Services is hosting the service on behalf of ECDC. 

The data subject has the right of recourse at any time to the European Data Protection Supervisor ([email protected]

Our data protection notice can be found here (Data protection notice)

Sex and gender equity in research 

We encourage our authors to follow the Sex and Gender Equity in Research (SAGER) guidelines and to take into account sex and gender considerations where relevant. Authors should use the terms sex (biological attribute) and gender (shaped by social and cultural circumstances) carefully in order to avoid confusing both terms. 

Article titles and/or abstracts should indicate clearly what sex(es) the study applies to. Authors should also describe in the background, (deleted where relevant here) whether sex and/or gender differences may be expected; report how sex and/or gender were accounted for in the design of the study; provide disaggregated data by sex and/or gender, where appropriate; and discuss respective results. If a sex and/or gender analysis was not conducted, the rationale should be given in the Discussion.

Appeals and complaints

Eurosurveillance has a procedure for handling appeals and complaints. All appeals and complaints should be sent the editorial office ([email protected]). 

For appeals against our decision on a manuscript, we involve two associate editors, who assess the appeal. Under exceptional circumstances, an editorial advisor with relevant expertise may be involved. 

Allegations related to research integrity or plagiarism, such as double publication, theft or misuse of data, or disputed authorship, are dealt with by the Editor-in-chief in accordance with COPE flowcharts and guidelines, involving the relevant persons or institutions as needed. 

Complaints about the length of time taken in processing a manuscript, our behaviour, etc. are dealt with by the editorial team. Final evaluation – if escalation to a higher authority for individual instances is necessary – is made by the Editor-in-chief, who will provide an annual report about major complaints to the associate editors and the publisher. 

Changes in authorship

Eurosurveillance has a policy for changes in authorship i.e. adding or removing authors. This policy reflects the stage of the publication process at which such changes are made/requested. 

Adding authors after submission before publication of the article 

In cases where during the processing of a manuscript, after submission and before publication of an article, editors notice an additional author’s name on the author list or if the corresponding author requests addition of a new author, the editorial team will ask the corresponding author to send an email to [email protected] in which they explain why the author should be added, state that the new author fulfils ICMJE authorship criteria and describe their detailed contributions; all co-authors should be in Cc of this email to ensure that they are informed ahead of publication. 

Adding authors after publication of the article 

In cases where the corresponding author requests the addition of a new author within a reasonable time after publication of the article, we proceed as above. In addition, co-authors should be asked by the corresponding author to actively confirm their consent to the author being added, in an email to [email protected]

Once confirmation has been obtained and consensus has been reached, changes will be made online and an author correction will be published in the next Eurosurveillance issue. In case of differing opinions we will follow the approach suggested in respective COPE flowcharts

Removing authors after submission before publication of the article 

In cases where editors notice an author’s name has been removed or if the corresponding author requests an author to be removed before publication, the Editor-in-chief will evaluate the request and explanation why they should be removed. The author concerned should be informed about the request by the editorial team or the corresponding author and should actively agree to be removed from the author list in an email to [email protected]. All co-authors should be in Cc of the email exchange to ensure that they are informed. 

Removing authors after publication of the article 

In cases where an author requests to be removed from article after its publication, the Editor-in-chief will evaluate the request and explanation why they wish to be removed. Hereafter, the editorial team informs the corresponding author about the request and asks for active consent by them and all co-authors in individual emails to [email protected] with the requesting author and all co-authors in copy. 

Once consent has been obtained by all parties for removing the author, changes will be made online and an author correction will be published in the next Eurosurveillance issue. In case of differing opinions we will follow approach suggested in respective COPE flowcharts

Copyright issues 

Except where otherwise stated, all manuscripts published after 1 January 2016 are published under the Creative Commons Attribution (CC BY) licence. The Authors or their affiliated institutions retain ownership of the copyright for their manuscript, but allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the Authors and source are cited in accordance with the detailed information provided in the licence. 

Eurosurveillance allows pre- and post-print archiving. All published articles are automatically deposited in PubMedCentral. 

When submitting an article, authors are requested to send a signed agreement with authors for each article, signed by the corresponding author on behalf of all authors. It should be scanned and sent to the Eurosurveillance office as part of the submission process using our online submission system

We, as many other journals and institutions, use a tool (iThenticate) to routinely check incoming submissions for overlap with published material. We then make a case-by-case decision on whether the similarities represent a reason for us not to accept the paper for publication. If we identify overlap of an extent that we consider critical, we inform the authors of this and attach the similarity report, which in our opinion is a useful tool that can help the authors to improve their manuscript. We emphasise here that this measure does not imply that the material was not correctly acknowledged and that it should not be mistaken for an accusation of fraud. However, even if cited correctly, verbatim copies of full sentences or paragraphs from published material including that of authors themselves, can constitute a breach of copyright, for which we as a journal can be held responsible. Our policy follows the opinion of the committee on publication ethics (COPE). 

Indexation in PubMed/MEDLINE

Long articles (before 2008 Eurosurveillance monthly release) have been indexed by MEDLINE since January 2001, while rapid communications (before 2008 Eurosurveillance weekly release) have been indexed by MEDLINE since January 2005. 

The Index Medicus abbreviation for Eurosurveillance is Euro Surveill

How to cite Eurosurveillance articles 

Eurosurveillance articles should be cited as indicated at the top of the web version of the articles, using the electronic page number. Although part of the online content appears in print, the page numbers in print compilations and pdf files should not be cited. Correct citations with electronic page numbers can be found at the top of each article on the website and also in the pdf and the print versions.

An example of a correct citation is:

Scheutz F, Møller Nielsen E, Frimodt-Møller J, Boisen N, Morabito S, Tozzoli R, Nataro JP, Caprioli A. Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011. Euro Surveill. 2011;16(24):19889. 

Become a reviewer 

If you think you could help us to peer-review articles, please register on our online submission system and provide as much detail as possible about your areas of expertise. 

Contacting the editorial team

If you have any questions about Eurosurveillance, please contact our editorial team at [email protected] 

ISSN numbers

The online and print formats of Eurosurveillance are assigned separate ISSNs.

Online content: ISSN 1560-7917

Print compilation: ISSN 1025-496X 

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error